HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tikellis, C. Articles by Cooper, M. E. Search for Related Content PubMed PubMed Citation Articles by Tikellis, C. Articles by Cooper, M. E. Social Bookmarking                What's this?

Improved Islet Morphology after Blockade of the Renin- Angiotensin System in the ZDF Rat

¹ Danielle Alberti Memorial Centre for Diabetic Complications, Baker Medical Research Institute, Melbourne, Victoria, Australia
² Howard Florey Institute of Experimental Physiology and Medicine, University of Melbourne, Parkville, Melbourne, Victoria, Australia
³ Department of Medicine, Royal Melbourne Hospital, Parkville, Victoria, Australia

The renin-angiotensin system (RAS) has an important role in the endocrine pancreas. Although angiotensin II has significant effects on cell proliferation and apoptosis, the contribution of the RAS to changes in islet structure and function associated with type 2 diabetes is yet to be defined. This study examined the specific effects of RAS blockade on islet structure and function in diabetes. Thirty-six male Zucker diabetic fatty (ZDF) rats, 10 weeks of age, were randomized to receive the angiotensin-converting enzyme inhibitor perindopril (8 mg/l in drinking water; n = 12), irbesartan (15 mg/kg via gavage; n = 12), or no treatment (n = 12) for 10 weeks. Results were compared with lean littermates (ZL) (n = 12) studied concurrently. ZDF rats had increased intra-islet expression of components of the RAS correlating with increased intraislet fibrosis, apoptosis, and oxidative stress. Disordered islet architecture, seen in ZDF rats, was attenuated after treatment with perindopril or irbesartan. Islet fibrogenesis was also diminished, as measured by picrosirius staining and expression of collagens I and IV. Gene expression of transforming growth factor-ß1 was increased in the ZDF pancreas (ZL, 1.0 ± 0.1; ZDF, 2.0 ± 0.3; P < 0.05) and reduced after blockade of the RAS (ZDF + P, 1.3 ± 0.2; ZDF + I, 1.5 ± 0.1; vs. ZDF, both P < 0.05). Improvements in structural parameters were also associated with functional improvements in first-phase insulin secretion. These findings provide a possible mechanism for the reduced incidence of new-onset diabetes that has been observed in clinical trials of RAS blockade.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				N. Nagai, K. Izumi-Nagai, Y. Oike, T. Koto, S. Satofuka, Y. Ozawa, K. Yamashiro, M. Inoue, K. Tsubota, K. Umezawa, et al. Suppression of Diabetes-Induced Retinal Inflammation by Blocking the Angiotensin II Type 1 Receptor or Its Downstream Nuclear Factor-{kappa}B Pathway Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4342 - 4350. [Abstract] [Full Text] [PDF]

				H. Muller, N. Schweitzer, O. Johren, P. Dominiak, and W. Raasch Angiotensin II stimulates the reactivity of the pituitary-adrenal axis in leptin-resistant Zucker rats, thereby influencing the glucose utilization Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E802 - E810. [Abstract] [Full Text] [PDF]

				S. Gilliam-Davis, V. S. Payne, S. O. Kasper, E. N. Tommasi, M. E. Robbins, and D. I. Diz Long-term AT1 receptor blockade improves metabolic function and provides renoprotection in Fischer-344 rats Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1327 - H1333. [Abstract] [Full Text] [PDF]

				M. R. Hayden, P. R. Karuparthi, C. M. Manrique, G. Lastra, J. Habibi, and J. R. Sowers A BRIEF COMMUNICATION: Longitudinal Ultrastructure Study of Islet Amyloid in the HIP Rat Model of Type 2 Diabetes Mellitus Experimental Biology and Medicine, June 1, 2007; 232(6): 772 - 779. [Abstract] [Full Text] [PDF]

				P. S. Leung The physiology of a local renin-angiotensin system in the pancreas J. Physiol., April 1, 2007; 580(1): 31 - 37. [Abstract] [Full Text] [PDF]

				S. Bokhari, Z. Israelian, J. Schmidt, E. Brinton, and C. Meyer Effects of Angiotensin II Type 1 Receptor Blockade on {beta}-Cell Function in Humans Diabetes Care, January 1, 2007; 30(1): 181 - 181. [Full Text] [PDF]

				K. Y. Chu, T. Lau, P.-O. Carlsson, and P. S. Leung Angiotensin II Type 1 Receptor Blockade Improves {beta}-Cell Function and Glucose Tolerance in a Mouse Model of Type 2 Diabetes Diabetes, February 1, 2006; 55(2): 367 - 374. [Abstract] [Full Text] [PDF]

				S. Kooptiwut, M. Kebede, S. Zraika, S. Visinoni, K. Aston-Mourney, J. Favaloro, C. Tikellis, M. C Thomas, J. M Forbes, M. E Cooper, et al. High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunction J. Mol. Endocrinol., August 1, 2005; 35(1): 39 - 48. [Abstract] [Full Text] [PDF]